Moreover, we find that “APL-like NPM1m AML” carries IDH1/2/TET2 mutations significantly more frequently, and DNMT3A mutations significantly less frequently, than the other NPM1m AML cases. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.